RegulatoryINSM

Insmed raises BRINSUPRI peak revenue target above $7 billion after 49% quarterly jump

A wave of specialty respiratory launches has been reshaping drug market economics in 2026, and Insmed Incorporated (Nasdaq: INSM) put its number on the table Thursday: $425.5 million in total sec

By Adaeze Nwosu·August 6, 2026·二〇二六年八月六日·2 min read

Source · 來源

sec.gov

Share · 分享

X in f w

← Back to the News Desk Filed · Regulatory

Related Dispatches

相關報導

News Desk →

01Regulatory
Glucotrack director Paul Goode resigns over merger conflict of interest
Post-combination integration carries governance risks that do not always resolve quietly. In a current report submitted to the…
September 18, 2026 · 2 min
02Regulatory
Cross Timbers Royalty Trust sets October payout as oil and gas volumes ease
Oil royalty trusts translate commodity cycles into monthly distributions with unusual directness. September's data for Cross…
September 18, 2026 · 2 min
03Regulatory
Auburn and Florida renew a deep rivalry with first-year coaches on both sidelines
Against the backdrop of an SEC Saturday that has most attention fixed on Oxford, Mississippi, where top-ten Ole Miss and LSU…
September 18, 2026 · 2 min

Elsewhere on the Desk

All Dispatches →

Deals

Boston Red Sox ride AL-wide collapse to playoff contention

September 19, 2026 · 2 min

Deals

US housing window opens as 6.7% rates thin the buyer pool

September 19, 2026 · 2 min

Deals

Trump outlines large U.S. military presence in Greenland under security deal with Denmark

September 18, 2026 · 2 min

Crypto加密

Bitcoin's weekend volatility exposes the structural gap inside BITI's hedging wrapper

September 18, 2026 · 2 min